| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 124.63B | 120.77B | 109.22B | 115.47B | 96.27B | 83.08B |
| Gross Profit | 41.19B | 39.27B | 32.72B | 36.70B | 35.54B | 27.97B |
| EBITDA | 13.27B | 13.26B | 9.63B | 15.84B | 17.63B | 11.15B |
| Net Income | 6.17B | 6.04B | 4.47B | 9.11B | 10.67B | 6.73B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 127.32B | 115.49B | 107.22B | 93.71B | 77.91B |
| Cash, Cash Equivalents and Short-Term Investments | 9.64B | 9.86B | 6.59B | 9.10B | 15.12B | 13.16B |
| Total Debt | 0.00 | 25.29B | 21.52B | 17.07B | 15.77B | 15.21B |
| Total Liabilities | -70.04B | 57.28B | 50.27B | 45.28B | 38.69B | 31.43B |
| Stockholders Equity | 70.04B | 70.04B | 65.22B | 61.94B | 55.02B | 46.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.83B | -5.16B | -5.07B | 4.50B | 16.33B |
| Operating Cash Flow | 0.00 | 11.28B | 7.94B | 12.96B | 12.24B | 18.87B |
| Investing Cash Flow | 0.00 | -8.50B | -10.70B | -15.43B | -9.04B | -6.42B |
| Financing Cash Flow | 0.00 | -13.90M | 1.69B | -2.35B | -2.59B | -9.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹228.60B | 34.83 | ― | 0.14% | -2.24% | 31.43% | |
69 Neutral | ₹151.02B | 7.59 | ― | 2.88% | -3.03% | 357.65% | |
69 Neutral | ₹171.93B | 40.43 | ― | 0.47% | 8.96% | 17.70% | |
66 Neutral | ₹194.71B | 27.33 | ― | 1.03% | 13.39% | 36.62% | |
64 Neutral | ₹175.46B | 32.36 | ― | 0.43% | 16.46% | 43.59% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ₹192.55B | 48.64 | ― | 0.48% | 0.43% | -42.29% |
DCM Shriram Limited has announced a Q2 FY26 Earnings Conference Call scheduled for October 30, 2025, at 4:00 PM IST. The call, which will include key members of the company’s senior management, follows the release of the company’s financial results for the quarter ended September 30, 2025. This event is significant for analysts and investors as it provides insights into the company’s financial health and strategic direction.